Verition Fund Management
ARNA

Verition Fund Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Verition Fund Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-52,000
Closed -$4.83M – 3224
2021
Q4 		$4.83M Buy
+52,000
New +$3.43M 0.03% 378

Verition Fund Management's ARNA Position: Q1 2022 in Review

Verition Fund Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 132,701 shares — an estimated $12.3M sold.

Verition Fund Management first reported a position in ARNA in Q4 2013 and held it in 8 quarters. The position peaked at $12.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Verition Fund Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Verition Fund Management sold 132,701 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $12.3M.
  • Verition Fund Management first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 8 quarters.
  • Verition Fund Management's Arena Pharmaceuticals Inc position peaked at $12.3M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.